COMMUNIQUÉS West-GlobeNewswire

New STING study opens up multi-billion dollar cancer immunotherapy market for LIDDS unique NanoZolid® technology

30/07/2018 - 09:16

The preclinical study proves that a single intratumoral injection of a NanoZolid® formulated STING-agonist has equal or better efficacy compared to multiple injections of a standard STING-agonist treatment, thereby [...]

Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate

30/07/2018 - 09:00

Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate Tokyo, Berlin, Basking Ridge, NJ – (July 30, 2018) – Daiichi Sankyo Company, Limited (hereafter, Daiichi [...]

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

30/07/2018 - 08:30

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 30 July 2018 at 9:30 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Changes to Biohit Oyj’s management

30/07/2018 - 08:30

Adjunct professor (molecular mircobiology) and computer science engineer Minna Mäki (b. 1969) has been appointed R&D and production director and as a member of the Management Team of Biohit Oyj starting July 30th [...]

CrownBio étend de nouveaux modèles humanisés destinés au développement d’immunothérapies ciblées à son centre de recherche de San Diego, en Californie

30/07/2018 - 08:03

Le programme d‘expansion des modèles humanisés commencera par les modèles PD-1, CTLA-4 et CD137 SAN DIEGO, 30 juill. 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , société internationale de services de découverte et de [...]

Shire plc : Miscellaneous

30/07/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 30 July 2018 Shire [...]

MediciNova Announces Full Enrollment in ALS Biomarker Clinical Trial

30/07/2018 - 01:00

LA JOLLA, Calif., July 29, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

Chembio Diagnostics Announces Collaboration with FIND to Develop Hepatitis C Virus Point-of-Care Diagnostic Test

28/07/2018 - 14:00

MEDFORD, N.Y. and GENEVA, July 28, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced a collaboration with the Foundation for [...]

Veritas Pharma Announces Loan to Marapharm and Cancellation of Stock Options

28/07/2018 - 00:51

VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that effective June 25, 2018, it [...]

Kalytera Therapeutics Announces Adjournment of 2018 Annual and Special Meeting

27/07/2018 - 23:08

SAN FRANCISCO and TEL AVIV, Israel, July 27, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company”, or “Kalytera”) (TSXV:KALY) (OTCQB:KALTF) announced today that the annual and special meeting of Kalytera [...]

CLS Holdings USA Appoints Frank Tarantino, CPA as Chief Financial Officer

27/07/2018 - 22:00

Adds Big Four Public Accounting and Public Company Experience LAS VEGAS, July 27, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences [...]

HEXO Supports Privatization of Retail Cannabis in Ontario

27/07/2018 - 19:20

GATINEAU, Quebec, July 27, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to hear reports that the Ontario government is considering the privatization of adult- [...]

HEXO appuie la privatisation des ventes au détail du cannabis en Ontario

27/07/2018 - 19:20

GATINEAU, Québec, 27 juill. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) est heureuse d’apprendre que le gouvernement de l’Ontario envisage la privatisation de la vente au [...]

INSYS Therapeutics Receives Complete Response Letter from FDA for Buprenorphine NDA

27/07/2018 - 18:50

PHOENIX, July 27, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY) announced that today it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the company [...]

Idera Pharmaceuticals Announces One-for-Eight Reverse Stock Split

27/07/2018 - 17:58

EXTON, Pa., July 27, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for [...]

CASMED to Report Second-Quarter 2018 Financial Results and Hold Conference Call on August 2

27/07/2018 - 17:12

BRANFORD, Conn., July 27, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED) , a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results [...]

The American Health Council Board of Nurses Welcomes Sarah Kavalauskas MSN, BSN, RN, PALS, ACLS, NRCME

27/07/2018 - 17:11

NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- The American Health Council is proud to appoint Sarah Kavalauskas MSN, BSN, RN, PALS, ACLS, NRCME to its Board of Nurses. Currently a Certified Nurse Practitioner at Health [...]

Cambrex to Announce Second Quarter 2018 Financial Results on August 2, 2018

27/07/2018 - 17:10

EAST RUTHERFORD, N.J., July 27, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]

Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

27/07/2018 - 17:05

IRVING, Texas, July 27, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced [...]